Literature DB >> 11435110

Solution structure of the LDL receptor EGF-AB pair: a paradigm for the assembly of tandem calcium binding EGF domains.

S Saha1, J Boyd, J M Werner, V Knott, P A Handford, I D Campbell, A K Downing.   

Abstract

BACKGROUND: From the observed structure and sequence of a pair of calcium binding (cb) epidermal growth factor-like (EGF) domains from human fibrillin-1, we proposed that many tandem cbEGF domains adopt a conserved relative conformation. The low-density lipoprotein receptor (LDLR), which is functionally unrelated to fibrillin-1, contains a single pair of EGF domains that was chosen for study in the validation of this hypothesis. The LDLR is the protein that is defective in familial hypercholesterolaemia, a common genetic disorder that predisposes individuals to cardiovascular complications and premature death.
RESULTS: Here, we present the solution structure of the first two EGF domains from the LDL receptor, determined using conventional NMR restraints and residual dipolar couplings. The cbEGF domains have an elongated, rod-like arrangement, as predicted. The new structure allows a detailed assessment of the consequences of mutations associated with familial hypercholesterolaemia to be made.
CONCLUSIONS: The validation of the conserved arrangement of EGF domains in functionally distinct proteins has important implications for structural genomics, since multiple tandem cbEGF pairs have been identified in many essential proteins that are implicated in human disease. Our results provide the means to use homology modeling to probe structure-function relationships in this diverse family of proteins and may hold the potential for the design of novel diagnostics and therapies in the future.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435110     DOI: 10.1016/s0969-2126(01)00606-2

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  9 in total

1.  Role of an intramolecular contact on lipoprotein uptake by the LDL receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochim Biophys Acta       Date:  2011-04-09

2.  NMR structure determination of proteins supplemented by quantum chemical calculations: detailed structure of the Ca2+ sites in the EGF34 fragment of protein S.

Authors:  Ya-Wen Hsiao; Torbjörn Drakenberg; Ulf Ryde
Journal:  J Biomol NMR       Date:  2005-02       Impact factor: 2.835

3.  Structure-Function Relationships of LDL Receptor Missense Mutations Using Homology Modeling.

Authors:  Sureerut Porntadavity; Nutjaree Jeenduang
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

4.  Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding.

Authors:  Hong-mei Gu; Ayinuer Adijiang; Matthew Mah; Da-wei Zhang
Journal:  J Lipid Res       Date:  2013-10-08       Impact factor: 5.922

5.  Molecular basis for LDL receptor recognition by PCSK9.

Authors:  Hyock Joo Kwon; Thomas A Lagace; Markey C McNutt; Jay D Horton; Johann Deisenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

6.  Structural basis for ligand capture and release by the endocytic receptor ApoER2.

Authors:  Hidenori Hirai; Norihisa Yasui; Keitaro Yamashita; Sanae Tabata; Masaki Yamamoto; Junichi Takagi; Terukazu Nogi
Journal:  EMBO Rep       Date:  2017-04-26       Impact factor: 8.807

7.  Ca2+ binding to complement-type repeat domains 5 and 6 from the low-density lipoprotein receptor-related protein.

Authors:  Olav M Andersen; Henrik Vorum; Bent Honoré; Hans C Thøgersen
Journal:  BMC Biochem       Date:  2003-08-18       Impact factor: 4.059

Review 8.  Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Authors:  Nicola Ferri
Journal:  Scientifica (Cairo)       Date:  2012-09-11

Review 9.  PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs.

Authors:  Nikolay Kuzmich; Elena Andresyuk; Yuri Porozov; Vadim Tarasov; Mikhail Samsonov; Nina Preferanskaya; Valery Veselov; Renad Alyautdin
Journal:  Molecules       Date:  2022-01-10       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.